graph Evidence gap map comparisons
avelumab based treatment
avelumab plus axitinib
mRCC - L1 - PDL1 negative 1
mRCC - L1 - PDL1 positive 4   
Comparator:  vs sunitinib; 
Risk of bias:  low;   some concerns;   high;  NA;